Effect of Soluble CD39 and PD-L1 Levels on Diagnosis and Prognosis of Lung Cancer Patients with Malignant Pleural Effusion

被引：0
|
作者：
Chen, M. [1 ]
Li, X. [2 ]
Wan, B. [1 ]
Zhu, S. [2 ]
Chen, C. [1 ]
Zhang, F. [2 ]
Song, Y. [3 ]
Lv, T. [2 ]
机构：
[1] Southern Med Univ, Sch Clin Med 1, Jinling Hosp, Dept Resp Med, Guangzhou, Peoples R China
[2] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp & Crit Care Med, Nanjing, Peoples R China
[3] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Soluble PD-L1; Soluble CD39; malignant pleural effusion (MPE);
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P36.08
引用
收藏
页码：S437 / S438
页数：2
相关论文
共 50 条
  • [21] Characteristics of Soluble PD-L1 and PD-1 Expression and Their Correlations With Immune Status and Prognosis in Advanced Lung Cancer
    Li, Ran
    Liang, Hongge
    Shang, Ying
    Yang, Zhengwu
    Wang, Keqiang
    Yang, Donghong
    Bao, Jing
    Xi, Wen
    Zhou, Dexun
    Ni, Wentao
    Gao, Zhancheng
    Mu, Xinlin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2025,
  • [22] ROLE FOR THE ECTONUCLEOTIDASE CD39: OUTCOME AND ASSOCIATION WITH PD-1/PD-L1 BASED CANCER IMMUNITY IN CLEAR CELL RENAL CELL CARCINOMA
    Murakami, Tetsushi
    Tanaka, Nobuyuki
    Hakozaki, Kyohei
    Takamatsu, Kimiharu
    Mikami, Shuji
    Yasumizu, Youta
    Takeda, Toshikazu
    Matsumoto, Kazuhiro
    Morita, Shinya
    Kosaka, Takeo
    Asanmua, Hiroshi
    Mizuno, Ryuichi
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2020, 203 : E238 - E239
  • [23] Monitoring of soluble PD-L1 levels in sera in non-small-cell lung cancer
    Igarashi, Tomoyuki
    Hanaoka, Jun
    Teramoto, Koji
    Daigo, Yataro
    CANCER SCIENCE, 2018, 109 : 1097 - 1097
  • [24] Monitoring of soluble PD-L1 levels in sera in non-small-cell lung cancer
    Teramoto, Koji
    Igarashi, Tomoyuki
    Sumimoto, Hidetoshi
    Daigo, Yataro
    CANCER SCIENCE, 2018, 109 : 653 - 653
  • [25] Synergistic upregulation of PD-L1 in tumor cells and CD39 in tumor-infiltrating CD8+ T cells leads to poor prognosis in patients with hepatocellular carcinoma
    Kang, Xi
    Zhao, Sinan
    Lin, Shan
    Li, Jing
    Wang, Shunxiang
    ONCOLOGY LETTERS, 2024, 28 (02)
  • [26] Diagnostic value of CD206+CD14+ macrophages in diagnosis of lung cancer originated malignant pleural effusion
    Pei, Xue-Bin
    Wu, Xiu-Zhi
    Yi, Feng-Shuang
    Zhai, Kan
    Shi, Huan-Zhong
    JOURNAL OF THORACIC DISEASE, 2019, 11 (07) : 2730 - +
  • [27] Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion
    Pan, Xue
    Zhong, Anyuan
    Xing, Yufei
    Shi, Minhua
    Qian, Bin
    Zhou, Tong
    Chen, Yongjing
    Zhang, Xueguang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (04) : 2161 - 2168
  • [28] Association between soluble PD-L1 and prognosis of non-small cell lung cancer (NSCLC) patients treated with immunotherapy
    Dellepiane, C.
    Coco, S.
    Dal Bello, M. G.
    Rossi, G.
    Rijavec, E.
    Biello, F.
    Tagliamento, M.
    Longo, L.
    Mora, M.
    Anselmi, G.
    Alama, A.
    Bennicelli, E.
    Grossi, F.
    Zullo, L.
    Beshiri, K.
    Bottini, A.
    Pronzato, P.
    Genova, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S851 - S851
  • [29] Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion
    Xu, Chunhua
    Qian, Lihua
    Yu, Like
    Zhang, Xiuwei
    Wang, Qingbo
    BIOMARKERS, 2015, 20 (04) : 271 - 274
  • [30] EFFECTS OF DIFFERENT LEVELS OF SOLUBLE PD-L1 PROTEIN ON THE GROWTH OF LEWIS LUNG CANCER TRANSPLANTED TUMOR
    Yang, K. N.
    Han, W.
    Qin, Y. J.
    Chen, L. N.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (02): : 537 - 542
12345